Sickle-cell disease.
Sickle-cell disease is one of the most common severe monogenic disorders in the world. Haemoglobin polymerisation, leading to erythrocyte rigidity and vaso-occlusion, is central to the pathophysiology of this disease, although the importance of chronic anaemia, haemolysis, and vasculopathy has been...
Main Authors: | Rees, D, Williams, T, Gladwin, M |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2010
|
Similar Items
-
Hemolysis-associated hypercoagulability in sickle cell disease: the plot (and blood) thickens!
by: Mark T. Gladwin, et al.
Published: (2008-01-01) -
Infections in sickle cell disease
by: Lily E.A. Scourfield, et al.
Published: (2024-11-01) -
Management of sickle cell disease in the community.
by: Brousse, V, et al.
Published: (2014) -
Precision Medicine and Sickle Cell Disease
by: Sara El Hoss, et al.
Published: (2022-09-01) -
The rationale for using hydroxycarbamide in the treatment of sickle cell disease
by: David C. Rees
Published: (2011-04-01)